RxDoctor Payments Data

Jami Veal

Optometrist · Paragould, ARNPI 1467531970

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 30.3% of the total. Reporting peaked in 2023 at $759 and has fallen 50.4% since, to $377 in 2025. Among optometrist clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,458in general payments, 2019–2025

Across 128 payments — averaging $27.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sight Sciences, Inc.$387
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$375
  • Mallinckrodt Hospital Products Inc.$310
  • Bausch & Lomb Americas Inc.$243
  • Novartis$169
  • plus $927 from 17 others

What the payments were for

  • Food & beverage$3,35297%
  • Entertainment$1053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,458 in reported general payments places this provider in the 95th percentile of 442 optometrist providers in Arkansas.

See all optometrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$15,773
Medicare patients
104
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate17$1,038
Latanoprost27$381
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat16$278
Timolol Maleate12$219

Paid to pharmacies, not to this prescriber.

Other optometrist in Paragould

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →